SELLAS Life Sciences Group Inc (NASDAQ:SLS) price closed higher on Tuesday, March 26, jumping 1.92% above its previous close.
A look at the daily price movement shows that the last close reads $1.04. The company’s 5Y monthly beta was ticking 2.35. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.91 and 52-week low of $0.50. The stock added 3.92% on its value in the past month.
SELLAS Life Sciences Group Inc, which has a market valuation of $58.46 million, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024. In this case, analysts estimate an annual EPS growth of 49.30% for the year and 19.40% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $13 million, with the likely lows of $13 million and highs of $13 million. Staying with the analyst view, there is a consensus estimate of $13 million for the company’s annual revenue in 2023. Per this projection, the revenue is forecast to grow 1,200.00% above that which the company brought in 2023.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give SLS a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that SLS’s price is at present -7.89% off the SMA20 and 23.35% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 49.98, with weekly volatility standing at 10.30%. The indicator jumps to 11.83% when calculated based on the past 30 days. SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s beta value is holding at 2.36, while the average true range (ATR) indicator is currently reading 0.14.
An analysis of the SELLAS Life Sciences Group Inc (NASDAQ:SLS) stock in terms of its daily trading volume indicates that the 3-month average is 1.37 million. However, this figure increases on the past 10-day timeline to an average of 2.55 million.
Current records show that the company has 55.15M in outstanding shares. The insiders’ percentage holdings are 0.92% of outstanding shares while the percentage share held by institutions stands at 10.11%. The stats also highlight that short interest as of Feb 29, 2024, stood at 4.51 million shares, which puts the short ratio at the time at 4.05. From this we can glean that short interest is 10.38% of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 3.12 million.
